Trivalent Influenza virus vaccine(MDCK cell) (Lanzhou Bailing/Kangtai Biological)

三价流感病毒裂解疫苗（MDCK细胞）（兰州百灵/康泰生物）

Report date: 2026/05/09 20:00:18

Base Information

Drug NameTrivalent Influenza virus vaccine(MDCK cell) (Lanzhou Bailing/Kangtai Biological)
Drug Alias NameN/A
ClassificationVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesLanzhou Bailing Biotechnology Co LtdShenzhen Kangtai Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLanzhou Bailing Biotechnology Co LtdShenzhen Kangtai Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A